A. A. M. Wilde

579 total citations
33 papers, 337 citations indexed

About

A. A. M. Wilde is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, A. A. M. Wilde has authored 33 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in A. A. M. Wilde's work include Cardiac electrophysiology and arrhythmias (15 papers), Cardiac Arrhythmias and Treatments (10 papers) and Cardiomyopathy and Myosin Studies (9 papers). A. A. M. Wilde is often cited by papers focused on Cardiac electrophysiology and arrhythmias (15 papers), Cardiac Arrhythmias and Treatments (10 papers) and Cardiomyopathy and Myosin Studies (9 papers). A. A. M. Wilde collaborates with scholars based in Netherlands, Italy and Germany. A. A. M. Wilde's co-authors include Christian van der Werf, A. H. Zwinderman, Irene M. van Langen, Marcel M. A. M. Mannens, Martin Hinterseer, Nynke Hofman, Michael W.T. Tanck, Hanno L. Tan, Stefan Kääb and Britt Maria Beckmann and has published in prestigious journals such as Circulation, European Heart Journal and Cardiovascular Research.

In The Last Decade

A. A. M. Wilde

25 papers receiving 322 citations

Peers

A. A. M. Wilde

CCM

SURGE

OSM

Albert R. Willems Netherlands

Manoj Obeyesekere Canada

Patrick Gambelli Italy

Guido De Ambroggi Italy

Sarah Costa Switzerland

Meena Fatah Canada

Iori Nagaoka Japan

Manuel Conti Italy

Ilaria Puggia Italy

Yoshihisa Enjoji Japan

Albert R. Willems Netherlands

A. A. M. Wilde

328 ×1.0

CCM

150 ×1.1

15 ×0.8

SURGE

7 ×0.6

OSM

10 ×1.0

Citations per year, relative to A. A. M. Wilde A. A. M. Wilde (= 1×) peers Albert R. Willems

Countries citing papers authored by A. A. M. Wilde

Since Specialization

Citations

This map shows the geographic impact of A. A. M. Wilde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. A. M. Wilde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. A. M. Wilde more than expected).

Fields of papers citing papers by A. A. M. Wilde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. A. M. Wilde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. A. M. Wilde. The network helps show where A. A. M. Wilde may publish in the future.

Co-authorship network of co-authors of A. A. M. Wilde

This figure shows the co-authorship network connecting the top 25 collaborators of A. A. M. Wilde. A scholar is included among the top collaborators of A. A. M. Wilde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. A. M. Wilde. A. A. M. Wilde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boekholdt, S. Matthijs, Adriënne van Randen, R. Nils Planken, et al.. (2025). Sex-specific performance of electrocardiographic criteria for left ventricular hypertrophy in elite athletes. Heart Rhythm. 23(2). 272–280. 1 indexed citations

Jongbloed, Jan D.H., Edgar T. Hoorntje, Paul A. van der Zwaag, et al.. (2025). Additional genetic variants in cardiomyopathy patients with the pathogenic PLN p.(Arg14del) founder variant. International Journal of Cardiology. 432. 133264–133264.

Kors, N., Nick R. Bijsterveld, Arend de Weger, et al.. (2025). Antithrombotic therapy and the risk of pocket hematoma after subcutaneous implantable cardioverter-defibrillator implantation. Journal of Interventional Cardiac Electrophysiology. 68(7). 1437–1446.

Theuns, Dominic A.M.J., Tom E. Verstraelen, Peter Paul H.M. Delnoy, et al.. (2022). Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy. Netherlands Heart Journal. 31(3). 89–99. 5 indexed citations

Boekholdt, S. Matthijs, et al.. (2022). Late gadolinium enhancement of the hinge point is a common finding in asymptomatic ELITE athletes. European Journal of Preventive Cardiology. 29(Supplement_1). 3 indexed citations

Glinge, Charlotte, Reza Jabbari, Veronica Dusi, et al.. (2022). Clinical risk factors associated with ventricular fibrillation during first ST-elevation myocardial infarction. EP Europace. 24(Supplement_1).

Bosman, Laurens P., Tom E. Verstraelen, Freyja H.M. van Lint, et al.. (2019). The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update. Netherlands Heart Journal. 27(10). 480–486. 29 indexed citations

Scholten, M. F., Jan G.P. Tijssen, Dominic A.M.J. Theuns, et al.. (2013). Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score. EP Europace. 16(1). 40–46. 30 indexed citations

Werf, Christian van der, A. H. Zwinderman, & A. A. M. Wilde. (2011). Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments. EP Europace. 14(2). 175–183. 118 indexed citations

10.

Verhorst, Patrick M.J., et al.. (2009). Towards a better risk stratification for sudden cardiac death in patients with structural heart disease. Netherlands Heart Journal. 17(3). 101–106. 3 indexed citations

11.

Remme, Carol Ann, Markus A. Engelen, Brendon P. Scicluna, et al.. (2007). Phenotype severity in mice carrying the sodium channel mutation SCN5A-1798insD depends on genetic background. European Heart Journal. 28. 740–740. 1 indexed citations

12.

Wilde, A. A. M., et al.. (2007). Bewaking van QT-tijdverlenging. Hoe groot het risico is en hoe apothekers het kunnen beperken. Data Archiving and Networked Services (DANS). 142(17). 30–34. 2 indexed citations

13.

Hofman, Nynke, A. A. M. Wilde, Stefan Kääb, et al.. (2006). Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system?. European Heart Journal. 28(5). 575–580. 89 indexed citations

14.

Bosker, Hans A., et al.. (2000). The MEDCAR study: Clinical evidence of recovery from atrial electrical remodeling after cardioversion of persistent atrial fibrillation. Data Archiving and Networked Services (DANS). 1 indexed citations

15.

Langen, Irene M. van, et al.. (2000). [Long QT-interval syndrome and investigation of heritability: psychological reactions in three generations in one family].. PubMed. 144(21). 995–9. 5 indexed citations

16.

Derksen, R. H. W. M., et al.. (2000). Scn5a mutation segregating with conduction abnormality but not with Brugada syndrome features in a family. Circulation. 102(18). 340–340. 3 indexed citations

17.

Langen, Irene M. van, et al.. (2000). Psychological distress in persons undergoing DNA-diagnostics for inherited autosomal dominant cardiac arrhythmia syndromes. European Heart Journal. 21. 554–554. 1 indexed citations

18.

Berg, Maarten P. van den, Alex V. Postma, Martin B. Rook, et al.. (1999). A single sodium channel mutation causing both long QT- and Brugada syndrome. Circulation. 100(18). 494–494. 6 indexed citations

19.

Berg, Maarten P. van den, et al.. (1999). Pacemaker-implantation prevents sudden death in a large family with LQT3. Circulation. 100(18). 642–642. 3 indexed citations

20.

Rook, Mieneke, et al.. (1998). Human SCN5A gene mutations alter Na-current kinetics and associate with VF in patients without structural heart disease. Data Archiving and Networked Services (DANS). 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact